EP2300495A4 - Solutions for tissue engineering and methods of use - Google Patents

Solutions for tissue engineering and methods of use

Info

Publication number
EP2300495A4
EP2300495A4 EP09763672A EP09763672A EP2300495A4 EP 2300495 A4 EP2300495 A4 EP 2300495A4 EP 09763672 A EP09763672 A EP 09763672A EP 09763672 A EP09763672 A EP 09763672A EP 2300495 A4 EP2300495 A4 EP 2300495A4
Authority
EP
European Patent Office
Prior art keywords
solutions
methods
tissue engineering
engineering
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09763672A
Other languages
German (de)
French (fr)
Other versions
EP2300495A1 (en
Inventor
Richard Hopkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Mercy Hospital
Original Assignee
Childrens Mercy Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Mercy Hospital filed Critical Childrens Mercy Hospital
Publication of EP2300495A1 publication Critical patent/EP2300495A1/en
Publication of EP2300495A4 publication Critical patent/EP2300495A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP09763672A 2008-06-11 2009-06-11 Solutions for tissue engineering and methods of use Withdrawn EP2300495A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6079608P 2008-06-11 2008-06-11
US6079008P 2008-06-11 2008-06-11
PCT/US2009/047115 WO2009152384A1 (en) 2008-06-11 2009-06-11 Solutions for tissue engineering and methods of use

Publications (2)

Publication Number Publication Date
EP2300495A1 EP2300495A1 (en) 2011-03-30
EP2300495A4 true EP2300495A4 (en) 2011-08-03

Family

ID=41417129

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09763672A Withdrawn EP2300495A4 (en) 2008-06-11 2009-06-11 Solutions for tissue engineering and methods of use

Country Status (5)

Country Link
US (1) US9682173B2 (en)
EP (1) EP2300495A4 (en)
AU (1) AU2009257400B2 (en)
CA (1) CA2727625A1 (en)
WO (1) WO2009152384A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2730650B1 (en) * 2011-07-06 2017-01-04 Histocell, S.L. Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress
AU2013273923C1 (en) * 2012-06-12 2016-11-03 Orthocell Ltd Method for producing a collagen membrane and uses thereof
US10585086B2 (en) 2014-06-12 2020-03-10 Hyglos Invest Gmbh Unmasking endotoxins in solution
EP2955518B2 (en) 2014-06-12 2022-01-26 bioMérieux Deutschland GmbH Unmasking endotoxins in solution
CN104771784B (en) * 2015-05-05 2018-01-09 北京帝康医药投资管理有限公司 One kind tissue de-cell liquid
US20170173214A1 (en) * 2015-12-21 2017-06-22 Medtronic Vascular, Inc. Methods for preparing dry cross-linked tissue
CN106172369B (en) * 2016-07-04 2018-01-12 拜欧迪赛尔（北京）生物科技有限公司 A kind of anti-oxidant de- Cell protective solutions of optimization
CN107441556B (en) * 2017-07-05 2020-07-17 北京大清生物技术股份有限公司 Polyamino acid-terminated tissue repair material and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118014A2 (en) * 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
US20070218038A1 (en) * 2006-03-17 2007-09-20 Pegasus Biologics, Inc. Stabilized, sterilized collagen scaffolds with active adjuncts attached

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
US8067149B2 (en) * 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
JP3880262B2 (en) * 1998-11-02 2007-02-14 株式会社カネカ Method for producing water-insolubilized regenerated collagen fiber
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US20020177223A1 (en) * 2001-03-12 2002-11-28 Ogle Mathew F. Methods and compositions for crosslinking tissue
US7078163B2 (en) * 2001-03-30 2006-07-18 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
WO2003024496A1 (en) * 2001-09-05 2003-03-27 Hans Biomed Corporation A process for preparing a biomaterial for tissue repair
US7494811B2 (en) * 2003-05-01 2009-02-24 Lifenet Health In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
CA2530533C (en) * 2003-06-27 2015-02-10 Ethicon, Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
WO2007083504A1 (en) * 2003-08-01 2007-07-26 Norimasa Nakamura Scaffold-free self-organized 3d synthetic tissue
WO2005044299A1 (en) * 2003-10-27 2005-05-19 University Of Pennsylvania Cytoprotective effects of ethyl pyruvate
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
JP2007526793A (en) * 2003-11-07 2007-09-20 ジーピー メディカル インコーポレイテッド Biodegradable drug-eluting stent
EP1756267A2 (en) * 2004-05-14 2007-02-28 Becton, Dickinson and Company Stem cell populations and methods of use
DE102004031216A1 (en) * 2004-06-28 2006-01-19 Siemens Ag Apparatus and method for charge equalization in series connected energy storage
WO2006026325A2 (en) * 2004-08-26 2006-03-09 Pathak Chandrashekhar P Implantable tissue compositions and method
US8445278B2 (en) 2005-03-01 2013-05-21 Medtronic, Inc. Process for producing decellularized biological tissues
CA2602050C (en) * 2005-03-11 2013-12-03 Wake Forest University Health Sciences Production of tissue engineered heart valves
US8038595B2 (en) * 2006-01-25 2011-10-18 Beth Israel Deaconess Medical Center Devices and methods for tissue transplant and regeneration
WO2007095193A2 (en) * 2006-02-10 2007-08-23 Tengion, Inc. Scaffolds for organ reconstruction and augmentation
WO2007120381A2 (en) * 2006-04-14 2007-10-25 Dexcom, Inc. Analyte sensor
US20080095757A1 (en) * 2006-10-23 2008-04-24 Now Health Group, Inc. Vitamin c compositions
US20100015710A1 (en) * 2008-04-25 2010-01-21 Sunghoon Jung Methods and Compositions for Isolating, Maintaining and Serially Expanding Human Mesenchymal Stem Cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118014A2 (en) * 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
US20070218038A1 (en) * 2006-03-17 2007-09-20 Pegasus Biologics, Inc. Stabilized, sterilized collagen scaffolds with active adjuncts attached

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KETCHEDJIAN A ET AL: "Recellularization of Decellularized Allograft Scaffolds in Ovine Great Vessel Reconstructions", THE ANNALS OF THORACIC SURGERY, vol. 79, no. 3, 1 March 2005 (2005-03-01), ELSEVIER, pages 888 - 896, XP004761944, ISSN: 0003-4975, DOI: 10.1016/J.ATHORACSUR.2004.09.033 *
PATHAK CHANDRASHEKAR P ET AL: "Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, vol. 69A, no. 1, 1 April 2004 (2004-04-01), pages 140 - 144, XP002639448, ISSN: 0021-9304 *
SCHMIDT C E ET AL: "Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering", BIOMATERIALS, vol. 21, no. 22, 15 November 2000 (2000-11-15), ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, pages 2215 - 2231, XP004210279, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(00)00148-4 *
See also references of WO2009152384A1 *

Also Published As

Publication number Publication date
CA2727625A1 (en) 2009-12-17
US9682173B2 (en) 2017-06-20
US20100035344A1 (en) 2010-02-11
EP2300495A1 (en) 2011-03-30
AU2009257400A1 (en) 2009-12-17
WO2009152384A1 (en) 2009-12-17
AU2009257400B2 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
HRP20180660T1 (en) Systems and methods for treatment of prostatic tissue
HK1172896A1 (en) Compounds and methods of use
EP2262450A4 (en) Implants and methods of use
HK1161094A1 (en) Compounds and methods of use
EG27167A (en) Microemulsifiers and methods of making and using same
PT2337568T (en) Methods and means for soft tissue engineering
EP2352452A4 (en) Systems and methods for treatment of prostatic tissue
IL217340A0 (en) Devices and methods for tissue engineering
HK1149933A1 (en) Diazacarbazoles and methods of use
EP2309860A4 (en) Monocyclic cyanoenones and methods of use thereof
IL218663A0 (en) Devices and methods for tissue engineering
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
IL236830A0 (en) Diazahomoadamantane derivatives and methods of use thereof
IL209548A0 (en) Diazacarbazoles and methods of use
EP2464227A4 (en) Compounds and methods of use thereof
EP2237727A4 (en) Tissue retractor and method of use thereof
IL206125A0 (en) Azaindolizines and methods of use
EP2242854A4 (en) Sirna compounds and methods of use thereof
EP2300495A4 (en) Solutions for tissue engineering and methods of use
EP2303101A4 (en) Laryngoscope blade and method of use
EP2328603A4 (en) Derivatives of apf and methods of use
GB0803055D0 (en) Surgical tool and method of use
HK1174620A1 (en) Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
GB0800556D0 (en) Method of treatment and treatment therefor
GB0820804D0 (en) Perinropril composition and method of use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110110

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110630

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140115

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/36 20060101AFI20160926BHEP

Ipc: A61F 2/24 20060101ALI20160926BHEP

INTG Intention to grant announced

Effective date: 20161025

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170307